Back to rankings
Winston Taylor

Winston Taylor

More information

Belgium

3

Industry focus: Healthcare and life sciences

Winston Taylor provides comprehensive legal support to pharmaceutical, biotech, medical device, diagnostics and research tool companies, backed by a strong international network. The team advises on patents, trademark and copyright disputes, as well as sector-specific regulatory matters related to clinical trials. Practice head Christian Dekoninck focuses on complex patent litigation in the life sciences sector, while Marie Keup advises across all areas of IP law.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘What sets Taylor Wessing’s healthcare & life sciences practice apart is the combination of deep sector specialisation and pan-European litigation capability, notably through their strong presence in UPC (Unified Patent Court) work. They understand that in life sciences, patent portfolios are strategic assets, and thus their advice always integrates national and UPC enforcement options from the outset.’

  • ‘Christian Dekoninck brings rare UPC litigation experience in life sciences, is always accessible, and excellent at framing high-level strategy (e.g. choosing jurisdictions, timing, tactical interplay between national and UPC paths).’

  • ‘Christian Dekoninck and Marie Keup are both very knowledgeable, have great associates, are insightful litigators and will also discourage taking action if they think it makes no sense.’

  • ‘Strong leadership and excellent response time from Christian Dekoninck’

Key clients

  • Abbott
  • Teva Pharmaceutical Industries Ltd.
  • Dana-Farber Cancer Institute
  • Mylan (Viatris)
  • NIPRO
  • Pfizer
  • Quantoom (Univercells)

Work highlights

Representing Abbott in various UPC and national cases to protect the intellectual property relating to their highly profitable continuous glucose monitoring Free Style Libre devices and systems.
Representing Viatris in the Belgian proceedings as well as in some of the proceedings before the General Court relating to patent infringement and market authorisation in the context of the generic launch of Dimethyl fumarate Mylan, the generic version of Biogen’s Tecfidera product, raising very interesting issues, in particular in relation to data exclusivity.
Representing the Dana-Farber Cancer Institute in proceedings against the Belgian State relating to their SPC applications. These proceedings raise various interesting questions relating to the SPC Regulation.
Practice head

Christian Dekoninck

Other key lawyers

Marie Keup; Séverine Bouvy